Open Clinical Trials:
CLINICAL TRIAL 21163
A Phase 1/2 Study of Regn7075 (Egfrxcd28 Costimulatory Bispecific Antibody) in Combination with Cemiplimab in Patients with Advanced Solid Tumors
Disease Site: Anus, Breast, Cervix, Colon, Esophagus, Kidney, Lip, Oral Cavity and Pharynx, Lung, Other Digestive Organ, Other Female Genital, Other Male Genital, Other Skin, Other Urinary, Pancreas, Prostate, Stomach
View Trial DetailsCLINICAL TRIAL 19000
Evaluation of Anti-Her2 and Anti-Her3 T-Helper Response in Primary Breast Cancer
Disease Site: Breast - Female
View Trial Details